Results 101 to 110 of about 7,033,015 (228)

Efficacy and Safety of Oral Non‐Statin Lipid‐Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
A network meta‐analysis of 43 randomized trials showed that oral combination therapies, particularly obicetrapib plus ezetimibe and bempedoic acid plus ezetimibe, achieved the greatest LDL‐C reduction with reassuring safety profiles, supporting their use as effective oral alternatives for patients with dyslipidaemia. ABSTRACT Introduction Dyslipidaemia
Tamer Hodrob, Reem J. Saad, Aya Hamdy, Mariam Saleh Alheneedy, Ahmed Mohamed Shehata Abdelfattah Elsayed, Elsaghir Ghazy, Hazem Ayesh   +6 more
wiley   +1 more source

Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations

, 2004
Background: Human plasma contains two lipid transfer proteins, cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP), which are crucial in reverse cholesterol transport.
De Vries, R, Scheek, L, Dullaart, RPF, Sluiter, Wim, Van Gent, T, Scheek, LM (Leo), Hattori, H, Tol, Aad, Dallinga-Thie, GM, Gent, T, Sluiter, WJ, Itoi, M, Ito, M, Borggreve, SE, Van Tol, A, Nagano, M, Vries, R.   +16 more
core   +1 more source

Hair curl type and scalp health, part 2: FTIR spectroscopy studies and analysis of inflammatory cytokines

International Journal of Cosmetic Science, Volume 48, Issue S1, Page S18-S32, November 2026.
In vivo ATR‐FTIR measurements revealed that hair wash frequency significantly affects the accumulation of sebum and skin residues on the scalp. When washing habits are standardized across different hair types, scalp sebum levels and composition are influenced by age, not by hair type.
Samuel Gourion‐Arsiquaud, Rezma Shrestha, Paul A. Cornwell   +2 more
wiley   +1 more source

Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein

, 2016
Recently, there has been a strong interest in the ability to increase levels of high density lipoprotein-cholesterol (HDL-C). This interest stems from the hypothesis that such an elevation in HDL-C will decrease the likelihood of cardiovascular disease ...
Christopher F. Thompson (1706539), Suzanne S. Eveland (2193658), Matt S. Anderson (2193676), Amjad Ali (51075), Milton L. Hammond (2193670), Qiu Guo (2193673), Denise P. Milot (2193652), Zhijian Lu (2193661), Nazia Quraishi (2193664), Peter J. Sinclair (2193679), Sheryl A. Hyland (2193667), Samuel D. Wright (2139484), Carl P. Sparrow (2193655)   +12 more
core   +1 more source

Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients

Immunology, Volume 179, Issue 3, Page 486-515, November 2026.
In this study, we revealed the disturbed metabolic status of circulating and tumour‐infiltrating CD4+ and CD8+ T cells in melanoma patients through targeted metabolomic and lipidomic (on sorted subsets) and at single cell level using the SCENITH method.
Hugo Brouque, Kareem Mahdy, Stephane Mouret, Sylvain Henry, Camille Niveau, Mélanie Cettour‐Cave, Martin Pelosse, Florence de Fraipont, Julie Charles, Andrei Turtoi, Philippe Saas, Caroline Aspord   +11 more
wiley   +1 more source

Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism

, 1997
Thyroid dysfunction is associated with multiple changes in lipoprotein metabolism, and we have determined the effects of thyroid dysfunction on plasma cholesteryl ester transfer protein (CETP) activity. CETP is a plasma protein that mediates the exchange
Kung, AWC, Tan, KCB, Shiu, SWM
core   +1 more source

Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol

Journal of Lipid Research, 1996
Cholesteryl ester transfer protein (CETP) mediates the exchange of phospholipids and neutral lipids between the plasma lipoproteins, and plays an important role in high density lipoprotein (HDL) metabolism.
M A Richardson, D T Berg, P A Johnston, D McClure, B W Grinnell   +4 more
doaj   +1 more source

Lipoprotein(a), Endothelial Dysfunction and Cardiovascular Disease

Journal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Lipoprotein(a) (Lp(a)) is a particle similar to low‐density lipoprotein cholesterol and is associated with apolipoprotein (A). High Lp(a) levels are a genetic, independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Endothelial cells, which form the continuous lining of the cardiovascular system, are crucial for vascular ...
Xianghui Zhou, Xiyuan Fang, Xin Zhou, Zhao Zhang, Yu Hu, Zhipeng Cheng   +5 more
wiley   +1 more source

Cholesteryl Ester Transfer Protein Inhibitors for Dyslipidemia in Cardiovascular Risk Patients: A Systematic Review and Meta-Analysis

Cholesteryl ester transfer protein inhibitors (CETPi) have emerged as promising agents for improving lipid profiles and potentially reducing cardiovascular risk.
Jingbo Zhang
core   +1 more source

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source